M4MM
DEA Assigns Specific Schedule I Listing and Drug Code to HHC
WASHINGTON – The Drug Enforcement Administration (DEA) has issued a final rule that formally lists hexahydrocannabinol (HHC) as a Schedule I controlled substance with its own dedicated drug code. The notice, published in the Federal ...
Allied Market Research: Global Cannabis Market to Generate $149B by 2031
PORTLAND – A report recently published by Allied Market Research projects the global Cannabis market will reach $148.9 billion by 2031, up from $25.7 billion in 2021 – a nearly sixfold increase over a decade, ...
Curaleaf Takes Full Control of Germany’s Four 20 Pharma
STAMFORD – Curaleaf Holdings Inc. closed the final chapter of a four-year German acquisition story, completing the buyout of the remaining 45% stake it did not previously own in Four 20 Pharma GmbH, a move ...
San Francisco Considers Ordinance for Cannabis Cafes
SAN FRANCISCO – Customers at licensed Cannabis retailers here could soon relax in dedicated Amsterdam-style cafes, consuming products on site while ordering prepared food and nonalcoholic drinks, following legislation introduced this week by Board of ...
Tilray Medical Expands Australian Medical Cannabis Offerings
NEW YORK – Tilray Medical, an internal division of Tilray Brands Inc., one of the largest global suppliers of pharmaceutical-grade medical Cannabis operating in 20 countries across five continents, announced expansion of its medical Cannabis ...
Cannabis Distributors Kiva Sales & Service and Petalfast Sign Letter of Intent to Combine
OAKLAND – Kiva Sales & Service (KSS), a leading sales and distribution agency focused on California’s Cannabis market, signed a letter of intent to combine operations with Petalfast, a national platform known for sales, distribution ...
New York Senate Health Committee Advances Bill for Out-of-State Medical Cannabis Access
ALBANY – The New York State Senate Health Committee approved legislation that would recognize medical Cannabis certifications from other states, granting those patients access to New York dispensaries under specific conditions. The measure, Senate Bill ...
DEA Assigns Specific Schedule I Listing and Drug Code to HHC
WASHINGTON – The Drug Enforcement Administration (DEA) has issued a final rule that formally lists hexahydrocannabinol (HHC) as a Schedule I controlled substance with its own dedicated drug code. The notice, published in the Federal ...
Allied Market Research: Global Cannabis Market to Generate $149B by 2031
PORTLAND – A report recently published by Allied Market Research projects the global Cannabis market will reach $148.9 billion by 2031, up from $25.7 billion in 2021 – a nearly sixfold increase over a decade, ...
Curaleaf Takes Full Control of Germany’s Four 20 Pharma
STAMFORD – Curaleaf Holdings Inc. closed the final chapter of a four-year German acquisition story, completing the buyout of the remaining 45% stake it did not previously own in Four 20 Pharma GmbH, a move ...
French Parkinson’s Patients Indicate Strong Support for Medical Cannabis and CBD Use
LOS ANGELES- A recent study published in Clinical Parkinsonism & Related Disorders reveals that a significant majority of individuals in France diagnosed with Parkinson's disease (PD) are in favor of utilizing medical cannabis and cannabidiol ...
Distru Secures $6 Million Series A to Expand Cannabis ERP Leadership
LOS ANGELES- Distru, a enterprise resource planning (ERP) platform serving the cannabis industry, has successfully secured $6 million in a Series A funding round led by Poseidon Investment Management. This strategic investment aims to bolster ...
DEA Schedules Cannabis Rescheduling Hearings for Early 2025
LOS ANGELES- The Drug Enforcement Administration (DEA) has outlined a schedule for witness testimony in the ongoing hearing concerning the potential reclassification of cannabis under the Controlled Substances Act. Chief Administrative Law Judge John Mulrooney ...
Week’s In Review: Ohio Legislature Considers Ban on Intoxicating Hemp Products; Florida’s Cannabis Legalization Measure Fails Despite Majority Support; Climate First Bank Introduces Cannabis-Focused Financial Services in Florida; DEA Postpones Cannabis Rescheduling Hearings to 2025
LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...
Curaleaf Secures Massachusetts’ First Cannabis Research License
LOS ANGELES- In a significant development for the cannabis industry, Curaleaf Holdings, Inc., a leading multistate operator, has secured Massachusetts' inaugural cannabis research facility license. The Massachusetts Cannabis Control Commission (CCC) unanimously approved the license ...
Cybin Reports 79% Remission in MDD with CYB003, Prepares for Phase 3 Trials
LOS ANGELES- Cybin Inc., has announced promising results from its Phase 2 study of CYB003, a proprietary deuterated psilocybin analog developed for the treatment of major depressive disorder (MDD). The study demonstrated that 79% of ...
Blunt Brunch Nationals: A Night of Glitz and Glam Celebrates Women in Cannabis
Las Vegas, NV – Blunt Brunch, a leading women’s empowerment organization in cannabis, is elevating its annual event to dazzling new heights. This year’s Blunt Brunch Nationals transforms from a traditional brunch into an elegant ...
GOP Senator Calls for Comprehensive Cannabis Reform, Criticizes Partial Measures
LOS ANGELES- In recent discussions on federal cannabis policy, several Republican senators have expressed diverse viewpoints regarding the regulation and legalization of cannabis. Senator Thom Tillis (R-NC) has advocated for treating cannabis similarly to tobacco, ...
Illinois Establishes Cannabis Research Institute to Advance Industry Understanding
LOS ANGELES- The State of Illinois, in collaboration with the City of Chicago, has inaugurated the Cannabis Research Institute (CRI), a joint initiative between the University of Illinois and the Discovery Partners Institute (DPI). This ...
GetTangi Corporation Eyes Regulatory Opportunities in Cryptocurrency Under Trump Administration
LOS ANGELES- In the aftermath of Donald Trump’s re-election to the White House, Ronald Strauss, CEO of GetTangi Corporation, a company integrating cryptocurrency with legal cannabis transactions, expressed a measured outlook on the potential regulatory ...
Robert F. Kennedy Jr. Nominated to Lead HHS, Poised to Drive Drug Policy Reforms
LOS ANGELES- President-elect Donald Trump has nominated Robert F. Kennedy Jr. to lead the U.S. Department of Health and Human Services (HHS), positioning him to influence significant drug policy reforms, including the promotion of psychedelics ...
What U.S. Employers Need to Know About Evolving Cannabis and Psychedelics Policies
LOS ANGELES- The November 5, 2024, elections have brought significant changes to state-level drug laws, requiring employers to reevaluate workplace policies, especially around cannabis and psychedelics. Key developments in Nebraska, Florida, North Dakota, South Dakota, ...
Trump’s Attorney General Pick Raises Hope for Cannabis Policy Reform
LOS ANGELES- President-elect Donald Trump has nominated Florida Representative Matt Gaetz as the next U.S. Attorney General, a move that could significantly influence federal cannabis policy. Gaetz, a vocal advocate for cannabis reform, has previously ...
Amethyst Health Secures Conditional Medical Cannabis License in New York
LOS ANGELES- a partnership between Black Star Wellness, LLC, and AYR Wellness Inc, has been conditionally awarded a vertically integrated medical cannabis license by the New York Cannabis Control Board. This license grants the right ...
Psilocybin Shows Potential for OCD and Tourette’s Treatment, Study Finds
LOS ANGELES- A new study published in Molecular Psychiatry has identified psilocybin, a psychedelic compound, as a promising candidate for the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome. Conducted by researchers at the Hadassah-Hebrew ...
